nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—Medrysone—Methylprednisolone—ankylosing spondylitis	0.219	0.322	CrCrCtD
Finasteride—Medrysone—Prednisolone—ankylosing spondylitis	0.195	0.286	CrCrCtD
Finasteride—Progesterone—Prednisolone—ankylosing spondylitis	0.143	0.21	CrCrCtD
Finasteride—Testosterone—Prednisolone—ankylosing spondylitis	0.124	0.182	CrCrCtD
Finasteride—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0645	0.204	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0429	0.136	CbGbCtD
Finasteride—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0429	0.136	CbGbCtD
Finasteride—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0332	0.105	CbGbCtD
Finasteride—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0322	0.102	CbGbCtD
Finasteride—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0252	0.0795	CbGbCtD
Finasteride—CYP3A4—Betamethasone—ankylosing spondylitis	0.0216	0.0682	CbGbCtD
Finasteride—CYP3A4—Prednisolone—ankylosing spondylitis	0.0213	0.0673	CbGbCtD
Finasteride—CYP3A4—Prednisone—ankylosing spondylitis	0.0201	0.0635	CbGbCtD
Finasteride—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0126	0.0397	CbGbCtD
Finasteride—Trauma—Prednisolone—ankylosing spondylitis	0.000195	0.0523	CcSEcCtD
Finasteride—Trauma—Triamcinolone—ankylosing spondylitis	0.000179	0.0481	CcSEcCtD
Finasteride—Trauma—Methylprednisolone—ankylosing spondylitis	0.000179	0.048	CcSEcCtD
Finasteride—Trauma—Dexamethasone—ankylosing spondylitis	0.000162	0.0436	CcSEcCtD
Finasteride—Trauma—Betamethasone—ankylosing spondylitis	0.000162	0.0436	CcSEcCtD
Finasteride—Trauma—Prednisone—ankylosing spondylitis	0.000141	0.038	CcSEcCtD
Finasteride—Injury—Prednisolone—ankylosing spondylitis	7.32e-05	0.0197	CcSEcCtD
Finasteride—Injury—Triamcinolone—ankylosing spondylitis	6.73e-05	0.0181	CcSEcCtD
Finasteride—Injury—Methylprednisolone—ankylosing spondylitis	6.72e-05	0.018	CcSEcCtD
Finasteride—Injury—Dexamethasone—ankylosing spondylitis	6.11e-05	0.0164	CcSEcCtD
Finasteride—Injury—Betamethasone—ankylosing spondylitis	6.11e-05	0.0164	CcSEcCtD
Finasteride—Breast disorder—Methylprednisolone—ankylosing spondylitis	5.58e-05	0.015	CcSEcCtD
Finasteride—Influenza—Triamcinolone—ankylosing spondylitis	5.35e-05	0.0144	CcSEcCtD
Finasteride—Injury—Prednisone—ankylosing spondylitis	5.32e-05	0.0143	CcSEcCtD
Finasteride—Bronchitis—Triamcinolone—ankylosing spondylitis	5.14e-05	0.0138	CcSEcCtD
Finasteride—Neoplasm—Methotrexate—ankylosing spondylitis	5.09e-05	0.0137	CcSEcCtD
Finasteride—Gynaecomastia—Methotrexate—ankylosing spondylitis	5.04e-05	0.0135	CcSEcCtD
Finasteride—Rhinitis—Triamcinolone—ankylosing spondylitis	4.29e-05	0.0115	CcSEcCtD
Finasteride—Rhinitis—Methylprednisolone—ankylosing spondylitis	4.28e-05	0.0115	CcSEcCtD
Finasteride—Pharyngitis—Triamcinolone—ankylosing spondylitis	4.25e-05	0.0114	CcSEcCtD
Finasteride—Erectile dysfunction—Prednisone—ankylosing spondylitis	3.89e-05	0.0105	CcSEcCtD
Finasteride—Immune system disorder—Methylprednisolone—ankylosing spondylitis	3.86e-05	0.0104	CcSEcCtD
Finasteride—Mental disorder—Methylprednisolone—ankylosing spondylitis	3.74e-05	0.0101	CcSEcCtD
Finasteride—Angioedema—Prednisolone—ankylosing spondylitis	3.7e-05	0.00994	CcSEcCtD
Finasteride—Breast disorder—Methotrexate—ankylosing spondylitis	3.69e-05	0.00992	CcSEcCtD
Finasteride—Angioedema—Triamcinolone—ankylosing spondylitis	3.4e-05	0.00915	CcSEcCtD
Finasteride—Angioedema—Methylprednisolone—ankylosing spondylitis	3.4e-05	0.00912	CcSEcCtD
Finasteride—Erectile dysfunction—Methotrexate—ankylosing spondylitis	3.25e-05	0.00874	CcSEcCtD
Finasteride—Angioedema—Dexamethasone—ankylosing spondylitis	3.09e-05	0.0083	CcSEcCtD
Finasteride—Angioedema—Betamethasone—ankylosing spondylitis	3.09e-05	0.0083	CcSEcCtD
Finasteride—Immune system disorder—Prednisone—ankylosing spondylitis	3.06e-05	0.00821	CcSEcCtD
Finasteride—Infection—Triamcinolone—ankylosing spondylitis	3.02e-05	0.00811	CcSEcCtD
Finasteride—Infection—Methylprednisolone—ankylosing spondylitis	3.01e-05	0.0081	CcSEcCtD
Finasteride—Mental disorder—Prednisone—ankylosing spondylitis	2.96e-05	0.00796	CcSEcCtD
Finasteride—Hypotension—Methylprednisolone—ankylosing spondylitis	2.84e-05	0.00762	CcSEcCtD
Finasteride—Pain—Prednisolone—ankylosing spondylitis	2.83e-05	0.0076	CcSEcCtD
Finasteride—Pharyngitis—Methotrexate—ankylosing spondylitis	2.81e-05	0.00754	CcSEcCtD
Finasteride—Infection—Betamethasone—ankylosing spondylitis	2.74e-05	0.00736	CcSEcCtD
Finasteride—Infection—Dexamethasone—ankylosing spondylitis	2.74e-05	0.00736	CcSEcCtD
Finasteride—Dyspnoea—Triamcinolone—ankylosing spondylitis	2.71e-05	0.00728	CcSEcCtD
Finasteride—Angioedema—Prednisone—ankylosing spondylitis	2.69e-05	0.00723	CcSEcCtD
Finasteride—Urticaria—Prednisolone—ankylosing spondylitis	2.63e-05	0.00706	CcSEcCtD
Finasteride—Pain—Triamcinolone—ankylosing spondylitis	2.6e-05	0.00698	CcSEcCtD
Finasteride—Hypotension—Betamethasone—ankylosing spondylitis	2.58e-05	0.00693	CcSEcCtD
Finasteride—Hypotension—Dexamethasone—ankylosing spondylitis	2.58e-05	0.00693	CcSEcCtD
Finasteride—Immune system disorder—Methotrexate—ankylosing spondylitis	2.55e-05	0.00686	CcSEcCtD
Finasteride—Mental disorder—Methotrexate—ankylosing spondylitis	2.48e-05	0.00665	CcSEcCtD
Finasteride—Hypersensitivity—Prednisolone—ankylosing spondylitis	2.44e-05	0.00654	CcSEcCtD
Finasteride—Urticaria—Triamcinolone—ankylosing spondylitis	2.42e-05	0.00649	CcSEcCtD
Finasteride—Urticaria—Methylprednisolone—ankylosing spondylitis	2.41e-05	0.00647	CcSEcCtD
Finasteride—Infection—Prednisone—ankylosing spondylitis	2.39e-05	0.00641	CcSEcCtD
Finasteride—Pain—Betamethasone—ankylosing spondylitis	2.36e-05	0.00634	CcSEcCtD
Finasteride—Pain—Dexamethasone—ankylosing spondylitis	2.36e-05	0.00634	CcSEcCtD
Finasteride—Hypersensitivity—Triamcinolone—ankylosing spondylitis	2.24e-05	0.00602	CcSEcCtD
Finasteride—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	2.24e-05	0.006	CcSEcCtD
Finasteride—Urticaria—Dexamethasone—ankylosing spondylitis	2.19e-05	0.00589	CcSEcCtD
Finasteride—Urticaria—Betamethasone—ankylosing spondylitis	2.19e-05	0.00589	CcSEcCtD
Finasteride—Dizziness—Prednisolone—ankylosing spondylitis	2.19e-05	0.00587	CcSEcCtD
Finasteride—Asthenia—Triamcinolone—ankylosing spondylitis	2.18e-05	0.00586	CcSEcCtD
Finasteride—Asthenia—Methylprednisolone—ankylosing spondylitis	2.18e-05	0.00585	CcSEcCtD
Finasteride—Pruritus—Triamcinolone—ankylosing spondylitis	2.15e-05	0.00578	CcSEcCtD
Finasteride—Pruritus—Methylprednisolone—ankylosing spondylitis	2.15e-05	0.00577	CcSEcCtD
Finasteride—Rash—Prednisolone—ankylosing spondylitis	2.09e-05	0.0056	CcSEcCtD
Finasteride—Dermatitis—Prednisolone—ankylosing spondylitis	2.08e-05	0.0056	CcSEcCtD
Finasteride—Headache—Prednisolone—ankylosing spondylitis	2.07e-05	0.00556	CcSEcCtD
Finasteride—Dizziness—Triamcinolone—ankylosing spondylitis	2.01e-05	0.0054	CcSEcCtD
Finasteride—Dizziness—Methylprednisolone—ankylosing spondylitis	2.01e-05	0.00539	CcSEcCtD
Finasteride—Infection—Methotrexate—ankylosing spondylitis	2e-05	0.00536	CcSEcCtD
Finasteride—Asthenia—Dexamethasone—ankylosing spondylitis	1.98e-05	0.00532	CcSEcCtD
Finasteride—Asthenia—Betamethasone—ankylosing spondylitis	1.98e-05	0.00532	CcSEcCtD
Finasteride—Pruritus—Dexamethasone—ankylosing spondylitis	1.95e-05	0.00524	CcSEcCtD
Finasteride—Pruritus—Betamethasone—ankylosing spondylitis	1.95e-05	0.00524	CcSEcCtD
Finasteride—Rash—Triamcinolone—ankylosing spondylitis	1.92e-05	0.00515	CcSEcCtD
Finasteride—Dermatitis—Triamcinolone—ankylosing spondylitis	1.92e-05	0.00515	CcSEcCtD
Finasteride—Rash—Methylprednisolone—ankylosing spondylitis	1.91e-05	0.00514	CcSEcCtD
Finasteride—Dermatitis—Methylprednisolone—ankylosing spondylitis	1.91e-05	0.00513	CcSEcCtD
Finasteride—Urticaria—Prednisone—ankylosing spondylitis	1.91e-05	0.00513	CcSEcCtD
Finasteride—Headache—Triamcinolone—ankylosing spondylitis	1.91e-05	0.00512	CcSEcCtD
Finasteride—Headache—Methylprednisolone—ankylosing spondylitis	1.9e-05	0.00511	CcSEcCtD
Finasteride—Hypotension—Methotrexate—ankylosing spondylitis	1.88e-05	0.00504	CcSEcCtD
Finasteride—Dizziness—Betamethasone—ankylosing spondylitis	1.82e-05	0.0049	CcSEcCtD
Finasteride—Dizziness—Dexamethasone—ankylosing spondylitis	1.82e-05	0.0049	CcSEcCtD
Finasteride—Dyspnoea—Methotrexate—ankylosing spondylitis	1.79e-05	0.00481	CcSEcCtD
Finasteride—Somnolence—Methotrexate—ankylosing spondylitis	1.79e-05	0.0048	CcSEcCtD
Finasteride—Hypersensitivity—Prednisone—ankylosing spondylitis	1.77e-05	0.00476	CcSEcCtD
Finasteride—Rash—Betamethasone—ankylosing spondylitis	1.74e-05	0.00467	CcSEcCtD
Finasteride—Rash—Dexamethasone—ankylosing spondylitis	1.74e-05	0.00467	CcSEcCtD
Finasteride—Dermatitis—Betamethasone—ankylosing spondylitis	1.74e-05	0.00467	CcSEcCtD
Finasteride—Dermatitis—Dexamethasone—ankylosing spondylitis	1.74e-05	0.00467	CcSEcCtD
Finasteride—Headache—Betamethasone—ankylosing spondylitis	1.73e-05	0.00464	CcSEcCtD
Finasteride—Headache—Dexamethasone—ankylosing spondylitis	1.73e-05	0.00464	CcSEcCtD
Finasteride—Asthenia—Prednisone—ankylosing spondylitis	1.72e-05	0.00463	CcSEcCtD
Finasteride—Pain—Methotrexate—ankylosing spondylitis	1.72e-05	0.00461	CcSEcCtD
Finasteride—Pruritus—Prednisone—ankylosing spondylitis	1.7e-05	0.00457	CcSEcCtD
Finasteride—Urticaria—Methotrexate—ankylosing spondylitis	1.6e-05	0.00429	CcSEcCtD
Finasteride—Dizziness—Prednisone—ankylosing spondylitis	1.59e-05	0.00427	CcSEcCtD
Finasteride—Rash—Prednisone—ankylosing spondylitis	1.52e-05	0.00407	CcSEcCtD
Finasteride—Dermatitis—Prednisone—ankylosing spondylitis	1.51e-05	0.00407	CcSEcCtD
Finasteride—Headache—Prednisone—ankylosing spondylitis	1.51e-05	0.00404	CcSEcCtD
Finasteride—Hypersensitivity—Methotrexate—ankylosing spondylitis	1.48e-05	0.00397	CcSEcCtD
Finasteride—Asthenia—Methotrexate—ankylosing spondylitis	1.44e-05	0.00387	CcSEcCtD
Finasteride—Pruritus—Methotrexate—ankylosing spondylitis	1.42e-05	0.00382	CcSEcCtD
Finasteride—Dizziness—Methotrexate—ankylosing spondylitis	1.33e-05	0.00357	CcSEcCtD
Finasteride—Rash—Methotrexate—ankylosing spondylitis	1.27e-05	0.0034	CcSEcCtD
Finasteride—Dermatitis—Methotrexate—ankylosing spondylitis	1.27e-05	0.0034	CcSEcCtD
Finasteride—Headache—Methotrexate—ankylosing spondylitis	1.26e-05	0.00338	CcSEcCtD
